Association of oncological response between the first‐line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinoma
Chikara Ohyama M.D., Ph.D.
Department of, Urology, Hirosaki, Japan
Department of, Advanced Blood Purification Therapy, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
Contribution: Conceptualization, Data curation, Project administration, Resources, Supervision
Search for more papers by this author
留言 (0)